PRESCRIBING · PART D · 2024
Total Rx claims
104
Beneficiaries
—
Total drug cost
$27K
Distinct drugs
5
Brand share
41.3%
Top prescribed drugs
Empagliflozin32 claims
Atorvastatin Calcium31 claims
Lisinopril19 claims
Insulin Nph Hum/Reg Insulin Hm11 claims
Losartan Potassium11 claims
QUALITY · MIPS · 2024
Final MIPS score
84.3
Quality
74.3
Cost
78.1
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.39%
Group
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CROSS-REFERENCE